OTC market in Central Europe 2013: Comparative analysis and development forecasts for 2013-2015

OTC market in Central Europe 2013: Comparative analysis and development forecasts for 2013-2015

$3,500.00

Publication ID
PMR1113006
Publication Date
November 15, 2013
Pages
237
Regions Covered
Publisher
This report examines the markets for over the counter remedies and nutritional supplements in six countries: Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic.  It presents comprehensive data describing conditions in the overall Central European market, in addition to market growth forecasts for each country.
 
Topics include value of the markets, sales totals from the pharmacy, non-pharmacy and Internet outlets, most popular OTC medicines and supplements. Leading corporate participants in the CE region are profiled. 
 
Why to Buy This Report
  • Represents a convenient and economical way to access all pertinent market information in one report
  • Offers a valuable historical perspective based upon lengthy observation of the Central European OTC drug market
  • Supports in-depth comparative analysis of important market indicators in each of the six countries examined in this report.
 
The Report Covers
  • The largest-selling OTC products in each featured country
  • Top regional manufacturers of OTC products
  • Top production companies specialising in over the counter preparations
  • OTC market values for each of the featured countries from 2009-2015
  • OTC market share of the overall pharmaceutical markets in each country
  • Separate analyses of the pharmacy segment market share in each country
  • Key trends that are currently driving market expansion; those projected to do so in the future
  • Comparison of the OTC markets in each country, including extensive market share analysis. 
 
Key Question Answered
  • Which CE country offers the highest value OTC drug and nutritional supplement market?
  • What types of planning strategies are being used by OTC product manufacturers in these Central European countries?
  • Which CE country offers the most OTC- friendly regulatory framework?
  • Which OTC markets display the highest levels of saturation?
  • What does the future hold? Which markets are poised to expand in 2013-2015?
 
Target Audience
  • Management professionals at regional OTC products companies – manufacturers
  • Wholesalers and distributors of pharmaceutical products in the CE region
  • OTC distributors operating on the Internet and through other non-pharmacy channels
  • Providers of research and consulting services; research institutions
  • Government agencies and embassies
  1. Methodology p.   13
  2. Executive summary p. 19
  3. OTC market in the CE region p. 21
    1. Share of individual OTC markets in 2012 p. 21
    2. Per capita OTC spending in CE countries p.   22
    3. Value of OTC market in CE countries 2010-2015 p. 22
    4. Average CAGR for OTC markets in CE countries 2011-2012 and 2013-2015 p. 23
    5. Selected important events and trends p. 24
      1. Health claims’ regulation p. 24
      2. Most widely trusted OTC products p. 25
        1. Cold and cough remedies p. 25
        2. Analgesics p. 26
        3. Vitamins p. 26
        4. Local brands p. 27
      3. Life expectancy at birth p. 28
  4. OTC markets in CE countries p. 29
    1. Poland p.   29
      1. Main trends and events on the OTC market p.   29
        1. Impact of the Reimbursement Act on the OTC segment p. 29
        2. Changes regarding online sales of OTC products p. 31
        3. Number of OTC products registered p. 31
        4. Number of prescriptions for OTC drugs p. 33
        5. Flu incidence p. 33
        6. Consumer behaviour p. 34
          1. Profiles of consumers of OTC products p.   34
          2. Spending on OTC products p. 34
          3. Consumer behaviour pertaining to non-pharmacy channel p. 36
          4. Preferences regarding packets’ sizes p. 38
          5. Frequency with which OTC products are bought p. 39
          6. Categories of drugs purchased p. 40
          7. Influence on OTC purchases p. 42
          8. Opinions on buying medicines online p. 42
        7. Restrictions regarding sales of OTC products based on narcotic drugs p. 43
        8. Planned expansion of product portfolio p. 44
      2. OTC market value p. 44
        1. OTC market value by distribution channel p.   44
        2. OTC market value by product status (drugs vs dietary supplements) p. 47
        3. Share of OTC as a proportion of the pharmaceutical market p.   47
        4. Value of the OTC product market between 2008 and 2015 p. 48
        5. Value of the dietary supplement market p.   49
        6. OTC products market by therapeutic categories p.   50
        7. Dietary supplements market by therapeutic categories p.   52
      3. Prices of OTC products p.   53
      4. Switch from Rx to OTC p.   54
      5. Best-selling OTC products p.   57
        1. OTC products p. 57
        2. OTC drugs p. 57
        3. Dietary supplements p. 58
    2. Romania p. 58
      1. Main trends and events on the OTC market p.   58
        1. Number of OTC products registered p. 58
        2. Imported OTC medicines aggressively promoted p.   60
        3. Over 50% of dietary supplements breach consumer rights p. 60
        4. Consumer behaviour p. 61
          1. Frequency with which OTC drugs are bought p. 61
          2. Knowledge of specific OTC drugs p. 62
          3. Most common health issues for which OTCs are used p. 62
          4. Frequency of certain other actions of Romanians associated with OTC drugs p. 63
        5. New players on the market p. 64
      2. OTC market value p. 64
        1. OTC market value by distribution channel p. 64
        2. OTC market value by product status (drugs vs dietary supplements) p.   64
        3. Share of OTC as a proportion of the pharmaceutical market p. 65
        4. Value of the OTC products market between 2006 and 2015 p. 66
        5. Value of the dietary supplements market p.   67
        6. OTC products market by therapeutic categories p. 69
        7. Dietary supplements market by therapeutic categories p. 69
      3. Prices of OTC products p. 71
      4. Switch from Rx to OTC p. 71
      5. Best-selling OTC products p. 71
        1. OTC drugs p. 71
        2. Dietary supplements p. 73
    3. Czech Republic p.   73
      1. Main trends and events on the OTC market p.   73
        1. OTC medicines no longer reimbursed p. 73
        2. Stricter control of online trade in drugs p. 73
        3. Number of OTC products registered p. 73
        4. Changes to homeopathy drugs registration p.   75
        5. Epidemiological trends – obesity p. 75
        6. New players on the market p.   76
        7. Consumer behaviour p. 78
          1. Preferences regarding packets’ sizes p. 78
          2. Preferences regarding weight-loss products p. 78
      2. OTC market value p.   79
        1. OTC market value by distribution channel p.   79
        2. OTC market value and volume by product status (drugs vs dietary supplements) p. 80
        3. Share of OTC as a proportion of the pharmaceutical market p.   81
        4. Value of the OTC product market between 2008 and 2015 p.   83
        5. Volume of the OTC drugs market p.   84
        6. Value of the dietary supplement market p. 86
        7. OTC product market by therapeutic categories p.   86
        8. Dietary supplements market by therapeutic categories p.   87
      3. Prices of OTC products p.   88
        1. OTC drugs p. 88
        2. Dietary supplements p. 90
      4. Best-selling OTC products p. 91
        1. By value p. 91
        2. By volume p. 92
        3. Dietary supplements p. 93
      5. Switch from Rx to OTC p.   94
    4. Hungary p. 95
      1. Main trends and events on the OTC market p. 95
        1. Actions to improve safety of dietary supplements p. 95
        2. Develompent of new dietary supplements p. 96
        3. Increasing importance of self-service pharmacies p. 96
        4. Number of dietary supplements registered p. 96
        5. Changes in rules pertaining to labelling of dietary supplements p.   97
        6. New OTC drugs in non-pharmacy sales p. 97
        7. Increasing importance of online communication and online distribution channels p. 97
        8. Regulations pertaining to borderline products p. 98
        9. Strategic cooperation agreements with pharmaceutical companies signed by the government p. 98
        10. General stores might be deprived of the option of selling OTC products p. 98
        11. Pharmacist chamber urges flat prices for OTC drugs p. 99
        12. Consumer behaviour p. 99
          1. Profiles of consumers of OTC products p.   99
          2. Spending on OTC products p. 99
          3. Consumer behaviour pertaining to non-pharmacy channel p. 100
          4. Frequency with which OTC products are bought p. 101
          5. Categories of drugs purchased p. 101
        13. Epidemiological trends p. 102
      2. OTC market value p. 103
        1. OTC market by distribution channel p. 103
        2. OTC market value by product status (drugs vs dietary supplements) p. 104
        3. Share of OTC as a proportion of the pharmaceutical market p. 105
        4. Value of the OTC products market between 2008 and 2015 p. 106
        5. Volume of the OTC products market between 2003 and 2012 p. 107
        6. Value of the dietary supplements market p. 108
        7. OTC market by therapeutic categories p. 110
        8. Dietary supplements market by therapeutic categories p. 113
      3. Prices of OTC products p. 115
        1. OTC drugs p. 115
        2. Dietary supplements p. 116
      4. Switch from Rx to OTC p. 118
      5. Best-selling OTC products p. 118
        1. By value p. 118
        2. By volume p. 120
    5. Slovakia p. 122
      1. Main trends and events on the OTC market p.   122
        1. Simplification of notification procedure for dietary supplements p. 122
        2. Epidemiological trends – flu incidence p. 122
        3. New products on the market – private label drugs p. 123
        4. E-healthcare bill p. 123
      2. OTC market value p. 123
        1. OTC market value by distribution channel p. 123
        2. OTC market value and volume by product status (drugs vs dietary supplements) p. 124
        3. Share of OTC as a proportion of the pharmaceutical market p. 125
        4. Value of the OTC products market between 2008 and 2015 p. 127
        5. Volume of the OTC drugs market p.   127
        6. Value of the dietary supplements market p. 128
        7. Dietary supplements market by volume p.   129
        8. OTC drugs market by therapeutic categories p. 129
        9. Dietary supplements market by therapeutic categories p. 130
      3. Prices of OTC products p. 131
        1. OTC drugs p. 131
        2. Dietary supplements p. 134
      4. Switch from Rx to OTC p. 135
      5. Best-selling OTC products      135
        1. By value p. 135
        2. By volume p. 136
    6. Bulgaria p. 138
      1. Main trends and events on the OTC market p.   138
        1. Online sales of dietary supplements and OTC drugs allowed p. 138
        2. Establishment of the BFSA p. 138
        3. Number of registered OTC products p.   139
        4. Freezing OTC prices p. 140
        5. Epidemiological trends – obesity p. 140
      2. OTC market value p.   140
        1. OTC market value by distribution channel p.   140
        2. Share of OTC as a proportion of the pharmaceutical market p.   140
        3. Value of OTC products market between 2009 and 2015 p.   141
        4. Volume of the OTC products market p.   143
        5. Value of the dietary supplements market p.   143
        6. OTC drugs market by therapeutic categories p.   145
          1. By value p. 145
          2. By volume p. 146
        7. Non-drugs market by therapeutic categories p. 146
          1. By value p. 146
          2. By volume p. 147
          3. Dermocosmetics p. 147
      3. Prices of OTC products p.   148
        1. Overall OTC market p. 149
        2. OTC drugs p. 149
        3. Dietary supplements p. 150
      4. Switch from Rx to OTC p. 151
      5. Best-selling OTC products p.   152
        1. By value p. 152
  5. Advertising of OTC products in CE countries p. 153
    1. Poland p. 153
    2. Romania p. 164
    3. Czech Republic p. 166
    4. Hungary p. 168
    5. Slovakia p. 173
    6. Bulgaria p. 174
  6. Key manufacturers p. 179
    1. Profiles of selected local manufacturers on OTC market in CE      179
    2. Key players in selected CE countries p. 198
    3. Poland p. 198
      1. OTC drugs p. 198
      2. Dietary supplements p. 198
    4. Romania p. 206
      1. Total OTC market p. 206
      2. Cold and flu market p. 206
      3. Dietary supplements p. 207
    5. Czech Republic p. 211
      1. OTC drugs      212
      2. Dietary supplements p. 213
    6. Hungary p. 213
      1. OTC drugs p. 213
      2. Dietary supplements p. 215
    7. Slovakia p. 215
      1. OTC drugs p. 215
      2. Dietary supplements p. 217
    8. Bulgaria p. 217
      1. Overall OTC market p. 217
      2. OTC drugs p. 218
      3. Dietary supplements p. 219
  7. List of graphs p. 223
  8. List of tables p. 229
  9. Contact PMR p. 234

 

 

List of graphs

  1. Value (€ bn) and change (%, y-o-y) of the OTC products market in CE, 2010-2015      19
  2. Share of individual OTC markets as a proportion of total OTC market in CE (%), 2012      21
  3. Per capita spending on OTC products in CE countries (€), 2012      22
  4. Value (€ bn) and change (%, y-o-y) of the OTC products market in CE, 2010-2015      22
  5. Average CAGR for OTC markets in the CE countries analysed for years 2011-2012      23
  6. Average CAGR for OTC markets in the CE countries analysed for years 2013-2015      24
  7. Male life expectancy at birth in CE countries analysed, 1990 and 2011      28
  8. Female life expectancy at birth in CE countries analysed, 1990 and 2011      28
  9. Number of OTC drugs authorised for marketing and dietary supplements notified in Poland, 2007 – January-July 2013      32
  10. Number of brands of OTC drugs and dietary supplements available on the Polish pharmacy market, 2009-H1 2013      32
  11. Change in the number of prescriptions for OTC products compared with other product groups in Poland, 2012 against 2011      33
  12. Flu incidence in Poland (million), 2000 – January-August 2013      34
  13. Have you reduced your spending on medicinal products in 2012 relative to 2011?      35
  14. Why did you reduce your spending on medicinal products in 2012 relative to 2011?      35
  15. Reasons for not buying drugs and dietary supplements outside pharmacies in Poland (%), 2013      36
  16. Reasons for buying drugs and dietary supplements outside pharmacies in Poland (%), 2013      37
  17. Preferences in terms of OTC drug and dietary supplement packet size in Poland (%), March 2013      38
  18. Frequency of purchasing particular medicinal products in Poland (%), 2012      38
  19. Frequency of consuming nutritional vitamin and herbal products in Poland (%), 2012      39
  20. Frequency of buying drugs/medicinal products online in Poland, in the past three months (%), 2012      40
  21. OTC drugs and dietary supplements most often bought outside pharmacies in Poland (%), March 2013      41
  22. Drugs most often used by women in Poland (%), 2012      41
  23. Drugs/OTC products most frequently purchased on the internet in Poland (%), 2012      42
  24. Opinions on buying drugs/medicinal products in online pharmacies compared with traditional pharmacies in Poland (%), 2012      43
  25. OTC products market in Poland, by sales channel and value share (%), 2012      45
  26. Pharmacy sales of OTC products in Poland, by product status and value share (%), 2011-2012      45
  27. Non-pharmacy sales of OTC products in Poland, by product status and value share (%), 2012      46
  28. OTC drugs market in Poland, by sales channel and value share (%), 2012      46
  29. Dietary supplements market in Poland, by sales channel and value share (%), 2012      47
  30. OTC products market in Poland, by product status and value share (%), 2012      47
  31. Share of OTC products as a proportion of the Polish pharmaceutical market (%), by value, 2011-2012      48
  32. Value (PLN bn) and change (%, y-o-y) of the OTC products market in Poland, 2008-2015      49
  33. Value (PLN bn) and change (%) of the dietary supplements market in Poland, 2011-2015      50
  34. Average prices of OTC products per packet in Poland (PLN) and change (%), 2002 – January-July 2013      53
  35. Number of changes of status from prescription drug to OTC medication in Poland, 2009 – January-July 2013      54
  36. Number of changes of status from OTC to Rx medication in Poland, 2010-2012      55
  37. Permits for new drug market launches in Romania, 2012      59
  38. Total number of dietary supplements in Romania of whose launch the IBA was notified, 2005-July 2013      60
  39. Frequency of consuming OTC drugs in Romania (%), April 2013      61
  40. Knowledge of specific OTC drugs among Romanians (%), April 2013      62
  41. Most common health issues for which OTCs are used in Romania (%), April 2013      62
  42. Frequency of certain actions of Romanians associated with OTC drugs (%), April 2013      63
  43. Sources of information about OTCs in Romania (%), April 2013      63
  44. Dietary supplements market in Romania, by sales channel and value share (%), 2011      64
  45. Pharmacy sales of OTC products in Romania, by product status and market share (%), 2012      65
  46. Share of OTC products as a proportion of the Romanian pharmacy market (%), by value, 2012      65
  47. Value (RON bn) and change (%, y-o-y) of the OTC products market in Romania, 2009-2015      67
  48. Value (RON m) and change (%, y-o-y) of the dietary supplements pharmacy market in Romania, 2005-2014      68
  49. OTC drugs market in Romania, by main product categories (€ m), 2012      69
  50. Frequently used dietary supplements in Romania (% of respondents), October 2009-September 2010      70
  51. Number of dietary supplements in the Czech Republic of whose launch the National Institute of Public Health was notified and change (%), 2007 – January-October 2012      75
  52. Prevalence of overweight, obesity and low weight in the Czech population (%), 2000, 2005, 2008, 2010 and 2013      76
  53. Number of Dr. Max private label dietary supplements in the Czech Republic, by category, November 2012      77
  54. Pharmacy sales of dietary supplements in the Czech Republic (%), by category of pharmacy, by value, September 2011-August 2012      79
  55. Sales volume (million packets) of OTC drugs and dietary supplements in the Czech Republic, pharmacy sales, 2007 – September 2011-August 2012      80
  56. Sales value (CZK bn) of OTC drugs and dietary supplements in the Czech Republic, pharmacy sales, 2007 – September 2011-August 2012      80
  57. Estimated share of OTC products as a proportion of the Czech pharmaceutical market (%), by value, 2012      81
  58. Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy products market in the Czech Republic (%), by volume, 2007 – September 2011-August 2012      81
  59. Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy products market in the Czech Republic (%), by value, 2007 – September 2011-August 2012      82
  60. Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market, pharmacy sales, by volume, 2011      82
  61. Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market, pharmacy sales, by value, 2011      83
  62. Value (CZK bn) and change (%, y-o-y) of the OTC products market in the Czech Republic, 2008-2015      83
  63. Number of packets of OTC drugs sold in the Czech Republic (million), 2009-Q1 2013      84
  64. Sales of Zentiva’s Paralen in different dosages in the Czech Republic, by volume, 2011-2012      85
  65. Sales of Zentiva’s Ibalgin in different dosages in the Czech Republic, by volume, 2011-2012      85
  66. Value (CZK bn) and change (%, y-o-y) of the dietary supplements pharmacy market in the Czech Republic, 2009-2014      86
  67. OTC market in the Czech Republic, by main product categories (%), H2 2011-H1 2012      87
  68. Market share of main dietary supplement categories in the Czech Republic (%), October 2011-September 2012      87
  69. Estimated sales value of main OTC drugs and dietary supplements categories in the Czech Republic (CZK m), H2 2011-H1 2012      88
  70. Average manufacturer price per packet of OTC drugs in the Czech Republic (CZK) and change (%), 2009-Q1 2013      89
  71. Average manufacturer price per dietary supplement packet in the Czech Republic (CZK), 2007 – September 2011-August 2012      91
  72. Number of Rx to OTC switches in the Czech Republic, 2010-2012      94
  73. Proportion of respondents who admit to taking vitamins and dietary supplements as a way of coping with stress in Hungary (%), November 2012      99
  74. Arguments against buying OTC products at places other than pharmacies in Hungary (%), June 2013      100
  75. Most popular categories of natural products among Hungarians (%), by sales, 2012      101
  76. Pharmacy sales of OTC products in Hungary (%), by product status, 2012      104
  77. Share of dietary supplements as a proportion of the total OTC product market in Hungary (%), by value, H1 2012      105
  78. Share of OTC products as a proportion of the Hungarian pharmaceutical market (%), by value, 2012      105
  79. Value (HUF bn) and change (%, y-o-y) of the OTC products market in Hungary, 2010-2015      106
  80. Value (HUF bn) and change (%, y-o-y) of the OTC drugs market in Hungary, 2010-2012      107
  81. Volume of the OTC products market in Hungary (million packets), 2003-2012      108
  82. Value (HUF bn) and change (%, y-o-y) of the dietary supplement pharmacy market in Hungary, 2005-2014      110
  83. OTC products market in Hungary, by main product categories (%), by value, H1 2012      111
  84. Sales of OTC preparations in the category of capillary stabilising agents in Hungary, by value (HUF m) and change (%), 2010-Q1 2013      112
  85. Main product categories of the dietary supplements market in Hungary (HUF bn), by value, 2008-2012      113
  86. Main product categories of the dietary supplements and vitamins non-pharmacy market in Hungary (%), by value, January-August 2012 – January-August 2013      114
  87. Main product categories of the dietary supplements and vitamins pharmacy market in Hungary (%), by value, January-August 2012 – January-August 2013      114
  88. Average pharmacy price per packet of OTC drugs in Hungary (HUF), 2009-2011      115
  89. Average price of dietary supplements in Hungary, in comparison with OTC products (HUF), January 2007 and September 2011      116
  90. Average difference in prices of new dietary supplements in Hungary in comparison with other comparable categories (%), January 2007-September 2011       117
  91. Number of acute respiratory infections and flu cases in Slovakia (‘000), 2009-2013      122
  92. Sales value of OTC drugs and dietary supplements in Slovakia (€ m), pharmacy sales, 2007 – October 2011-September 2012      124
  93. Share of OTC drugs and dietary supplements as a proportion of the OTC products pharmacy market in Slovakia (%), by value, 2007 – October 2011-September 2012      124
  94. Share of OTC drugs and dietary supplements as a proportion of the OTC products pharmacy market in Slovakia (%), by volume, 2007 – October 2011-September 2012      125
  95. Estimated share of OTC products as a proportion of the Slovak pharmaceutical market (%), by value, 2012      125
  96. Share of OTC drugs and dietary supplements as a proportion of the Slovak pharmaceutical market (%), pharmacy sales, by volume, 2011 and October 2011-September 2012      126
  97. Share of OTC drugs and dietary supplements as a proportion of the Slovak pharmaceutical market (%), pharmacy sales, by value, 2011 and October 2011-September 2012      126
  98. Value (€ m) and change (%, y-o-y) of the OTC products market in Slovakia, 2008-2015      127
  99. Number of OTC drug packets sold in Slovakia (million), 2009-H1 2013      128
  100. Value (€ m) and change (%, y-o-y) of the dietary supplements pharmacy market in Slovakia, 2007-2014      128
  101. Volume of dietary supplement pharmacy sales in Slovakia (million packets), 2007 – October 2011-September 2012      129
  102. OTC market in Slovakia, by main product categories (%), by value, October 2011-September 2012      129
  103. Market share of main dietary supplement categories in Slovakia (%), October 2011-September 2012      130
  104. Estimated sales value (€ m) of main OTC drugs and dietary supplement categories in Slovakia, October 2011-September 2012      131
  105. Average price per OTC drug packet in Slovakia (€), 2009-H1 2013      132
  106. Average manufacturer price per packet of dietary supplements in Slovakia (€), 2007 – October 2011-September 2012      134
  107. Number of OTC drugs registered in Bulgaria, by most popular ATC categories, June 2013      139
  108. Share of OTC products as a proportion of the Bulgarian pharmaceutical market (%), by value, 2012      141
  109. Value (BGN m) and change (%, y-o-y) of the OTC products market in Bulgaria, 2009-2015      141
  110. Value (BGN m) and change (%, y-o-y) of the OTC drugs market in Bulgaria, 2011-2012      142
  111. Volume (million packets) and change (%, y-o-y) of the OTC drugs market in Bulgaria, 2011-2012      143
  112. Value (BGN m) and change (%) in the dietary supplements pharmacy market in Bulgaria, 2009-2014      144
  113. Sales value of main OTC drug categories in Bulgaria (€ m), 2012      145
  114. Average price per packet of OTC products, by selected leading manufacturers in Bulgaria (BGN), 2012      149
  115. Advertising spending of companies in the pharmaceutical sector in Poland (PLN bn) and change (%), 2009-H1 2013      155
  116. Share of individual media channels in advertising expenditure of the pharmaceutical sector in Poland (%), 2012      155
  117. Individual manufacturers’ advertising expenditure in the pharmaceutical sector in Poland (PLN m), 2012      156
  118. Share of selected categories in advertising expenditure of the pharmaceutical sector (%), 2012      157
  119. Share of selected categories in advertising expenditure of the pharmaceutical sector (%), H1 2013      157
  120. Expenditure on TV advertising in the pharmaceutical sector in Poland (PLN m) and change (%), 2011-2012      158
  121. Share of individual manufacturers in TV advertising expenditure of the pharmaceutical sector in Poland (%), 2012      158
  122. Expenditure on radio advertising in the pharmaceutical sector in Poland (PLN m) and change (%), 2011-2012      159
  123. Share of individual manufacturers in radio advertising expenditure of the pharmaceutical sector in Poland (%), 2012      160
  124. Expenditure on magazine advertising in the pharmaceutical sector in Poland (PLN m) and change (%), 2011-2012      160
  125. Share of individual manufacturers in magazine advertising expenditure of the pharmaceutical sector in Poland (%), 2012      161
  126. Expenditure on newspaper advertising in the pharmaceutical sector in Poland (PLN m) and change (%), 2011-2012      161
  127. Share of individual manufacturers in newspaper advertising expenditure of the pharmaceutical sector in Poland (%), 2012      162
  128. Expenditure on outdoor advertising of the pharmaceutical sector in Poland (PLN m) and change (%), 2006-2012      163
  129. Expenditure on transit advertising of the pharmaceutical sector in Poland (PLN m) and change (%), 2010-2012      163
  130. Spending on OTC products advertising in the Czech Republic (CZK m), by product category, 2010-H1 2013      167
  131. Spending on online pharmaceutical advertising in the Czech Republic (CZK) and change (%), 2011-Q1 2013      168
  132. Advertising spending of OTC manufacturers in Hungary (HUF bn) and change (%), 2009-2012      170
  133. 10 top categories of OTC products in terms of advertising spending in Hungary, by amount spent (HUF bn), 2010-2012      170
  134. Krka Group organisation scheme, H1 2013      180
  135. Krka global revenues and net profit (€ m), 2005-H1 2013      180
  136. Krka global revenues from OTC drugs (€ m) and y-o-y change (%), 2011-H1 2013      181
  137. Krka global sales (€ m), by region, 2012-H1 2013      181
  138. Krka sales in CE countries analysed (€ m), H1 2013      183
  139. Krka global OTC sales (%), by product groups, 2012      183
  140. Gedeon Richter global revenues and net profit (€ m), 2006-H1 2013      184
  141. Sopharma global revenues and net profit (€ m), 2008-H1 2013      187
  142. Sopharma OTC drugs with most substantial increase in sales (%, y-o-y), 2012      188
  143. USP Zdrowie revenue and net profit (€ m), 2011-2012      189
  144. US Pharmacia revenue and net profit (€ m), 2009-2012      190
  145. Product structure for USP Zdrowie/US Pharmacia in Poland, by number of products in specific categories (%), September 2013      190
  146. Walmark global turnover (€ m) and change (%, y-o-y), 2006/2007-2012/2013      192
  147. Top Walmark’s dietary supplement brands, by volume (‘000 packets), 2012      193
  148. Walmark a.s. turnover (€ m), and change (% y-o-y), 2007/2008-2012/2013      194
  149. Walmark sales revenues in Slovakia (€ m) and change (%, y-o-y), 2011-2012      195
  150. Walmark sales revenues in Romania (€ m) and change (%, y-o-y), 2006-2012      195
  151. Walmark sales revenues in Poland (€ m) and change (%, y-o-y), 2008-2011      196
  152. Walmark sales revenues in Hungary (€ m) and change (%, y-o-y), 2010-2012      196
  153. Walmark sales revenues (€ m) and change (%, y-o-y) in Bulgaria, 2008-2012      197
  154. Walmark sales revenues in Bulgaria, by product (%), 2011      197

List of tables

  1. Euro/LCU change (%, y-o-y) in the CE countries analysed, 2012-2015      14
  2. GDP real change (%, y-o-y) in the CE countries analysed, 2012-2015      14
  3. GDP deflator change (%, y-o-y) in the CE countries analysed, 2012-2015      15
  4. Annual average exchange rates used for the report (€ to national currency), 2007-2012      16
  5. Most widely trusted cold/cough remedies in selected CEE countries, 2006-2012      25
  6. Most widely trusted analgesics in selected CEE countries, 2006-2012      26
  7. Most widely trusted vitamins in selected CEE countries, 2006-2012      27
  8. Most widely trusted local brands in selected CEE countries, 2006-2012      27
  9. Effect of the new Reimbursement Act on companies in Poland (%), 2012      30
  10. Proportion of Poles buying OTC drugs (%), by sex, age and education, 2012      34
  11. Selected planned marketing of new OTC products in Poland, 2013+      44
  12. OTC product pharmacy market in Poland, by main product categories (%), 2012      51
  13. OTC drug non-pharmacy market in Poland, by main product categories (%), by value, 2010-2012      51
  14. OTC drug non-pharmacy market in Poland, by main product categories (%), by volume, 2011-2012      51
  15. Sales value (PLN m) and market share (%) of main dietary supplement categories in Poland, January-October 2012      52
  16. Average pharmacy margin on OTC products in comparison with other pharmacy products in Poland (%), 2011-2012      53
  17. Changes in medicinal status (Rx to OTC switch) in Poland, 2011-July 2013      56
  18. Top 6 best-selling OTC products in Poland, by sales value (PLN m), 2011-2012      57
  19. Top 10 best-selling OTC drugs in Poland, by sales value (PLN m), 2011-2012      57
  20. Top 10 best-selling OTC dietary supplements in Poland, by sales value (PLN m), 2011-2012      58
  21. Total number of dietary supplements in Romania of whose launch the IBA and other institutions were notified, by August 2013      59
  22. Sales value (€ m) and y-o-y change (%) in dietary supplement categories in Romania, by main ATC category, 2010 – January-September 2012      70
  23. Top 10 best-selling OTC drugs in Romania, by sales value (€ m), 2012      71
  24. Top 7 best-selling OTC brands in terms of volume in Romania (million units), March 2012-February 2013      72
  25. Top 5 best-selling OTC brands in terms of volume in Romania (million units), Q1 2013      72
  26. Top 4 best-selling OTC brands in terms of volume in Romania (million units), June 2012-May 2013      72
  27. Number of OTCs and homeopathic drugs (SUKL codes) registered with and cleared for trade by the SUKL in the Czech Republic, 2009-2012      74
  28. Number of OTCs and homeopathic drugs (MA numbers) registered with and cleared for trade by the SUKL in the Czech Republic, 2009-2012      74
  29. Preferred weight-loss products in the Czech Republic and Slovakia (%), 2012      78
  30. Average price per drug packet of OTC drugs by selected leading manufacturers in the Czech Republic (CZK), 2011-H1 2013      90
  31. Average price per drug packet of selected best-selling OTC drugs in the Czech Republic (CZK), 2012      90
  32. Selected 14 best-selling OTC drugs in the Czech Republic, wholesale sales, by value (CZK m), 2012      91
  33. Selected 20 best-selling OTC drugs in the Czech Republic, by value (CZK m), Q1 2013      92
  34. Best-selling OTC products at a sample online pharmacy in the Czech Republic, by value, August 2013      92
  35. Best-selling OTC drugs in the Czech Republic, wholesale sales, by volume (‘000 packets), 2012      93
  36. Best-selling OTC drugs in the Czech Republic, wholesale sales, by volume (‘000 packets), Q1 2013      93
  37. Market share and change in sales value of best-selling dietary supplements in the Czech Republic (%), by value, October 2011-September 2012      94
  38. Changes in medicinal status (Rx to OTC switch) in the Czech Republic, 2011-2012      95
  39. Dietary supplements for increasing virility considered to be dangerous in Hungary, 2012      96
  40. Number of dietary supplements in Hungary of whose launch the National Institute for Food and Nutrition Science was notified, 2004 – January-November 2012      97
  41. Percentage of families which spent money on Rx drugs and OTC products in Hungary in the past month (%), 2006-2012      100
  42. Money spent on Rx drugs and OTC products during the past month in Hungary (HUF), 2006-2012      100
  43. OTC products bought at places other than pharmacies in the past 12 months in Hungary (%), June 2013      102
  44. OTC drugs market in Hungary, by main product categories (€ m), 2010-2012      111
  45. Average price per packet of top best-selling OTC preparations in the category of capillary stabilising agents in Hungary (HUF), 2012      115
  46. Average price per packet of selected best-selling OTC antispasmodics (drugs for functional bowel disorders) in Hungary (HUF), 2012      116
  47. Average prices per packet of dietary supplements by top manufacturers in Hungary (HUF), July 2012-June 2013      117
  48. Average prices per packet of top best-selling dietary supplements in Hungary (HUF), July 2012-June 2013      118
  49. Best-selling OTC drugs in Hungary, by value (HUF bn), 2012      119
  50. Best-selling OTC antispasmodics (drugs for functional bowel disorders) in Hungary, by value (HUF ‘000), 2012      119
  51. Best-selling OTC antispasmodics in combination with analgesics in Hungary, by value (HUF ‘000), Q1 2012-Q4 2012      119
  52. Best-selling OTC preparations in the category of capillary stabilising agents in Hungary, by value (HUF m), 2010-Q1 2013      120
  53. Best-selling dietary supplements in Hungary, by value (HUF), July 2012-June 2013      120
  54. Best-selling OTC antispasmodics (drugs for functional bowel disorders) in Hungary, by volume (packets), Q1 2012-Q4 2012      121
  55. Best-selling OTC antispasmodics in combination with analgesics in Hungary, by volume (packets), Q1 2012-Q4 2012      121
  56. Best-selling OTC preparations in the category of capillary stabilising agents in Hungary, by volume (number of packets), 2010-Q1 2013      121
  57. Sales value (€), volume (packets) and shares of homeopathic OTC drugs in Slovakia, 2012      130
  58. Average price per packet of OTC drugs by selected leading manufacturers in Slovakia (€), manufacturer prices, 2010-H1 2013      132
  59. Average price per drug packet of OTC drugs by selected leading manufacturers in Slovakia (€), consumer prices, 2012-H1 2013      133
  60. Average prices per packet of best-selling OTC drugs in Slovakia (€), 2012      133
  61. Average prices per packet of best-selling OTC drugs in Slovakia (€), H1 2013      134
  62. Top 10 best-selling OTC drugs in Slovakia, by value (€ m), 2012      135
  63. Top 10 best-selling OTC drugs in Slovakia, by value (€ m), H1 2013      136
  64. Selected top 18 best-selling OTC drugs in Slovakia, by volume, 2012      137
  65. Consumption of top 10 OTC medicines in Slovakia, Q1 2013      137
  66. Sales value (€ m) and y-o-y change (%) in main OTC drug categories in Bulgaria, 2012      145
  67. Sales volume (million packets) and y-o-y change (%) in main OTC drug categories in Bulgaria, 2012      146
  68. Sales value (€ m) and y-o-y change (%) in main OTC non-drug categories in Bulgaria, 2012      146
  69. Sales volume (million packets) and y-o-y change (%) in main OTC non-drug categories in Bulgaria, 2012      147
  70. Sales value (BGN m) and y-o-y change (%) in main dermocosmetics categories in Bulgaria, 2012      148
  71. Average price per packet of OTC products in Bulgaria (BGN), by product status, 2010-2012      148
  72. Average price per packet of OTC drugs, by selected leading manufacturers in Bulgaria (BGN), 2012      150
  73. Average price per packet of best-selling OTC drugs in Bulgaria (BGN), 2012      150
  74. Average price per packet of dietary supplements, by selected leading manufacturers in Bulgaria (BGN), 2012      151
  75. Average prices per packet of best-selling dietary supplements in Bulgaria (BGN), 2012      151
  76. Top 10 best-selling OTC drugs in Bulgaria, by sales value (BGN m), 2012      152
  77. Top 10 best-selling OTC dietary supplements in Bulgaria, by sales value (BGN m), 2012      152
  78. Three leading TV advertisers of OTC products in Romania (GRP), January-September 2012      165
  79. Nine leading TV advertisers of OTC products in Romania (GRP), January-February 2013      165
  80. Selected 12 leading TV advertisers of OTC products in Romania (GRP), H1 2013      165
  81. Reckitt Benckiser Romania OTC drug TV advertisements, by highest frequency, January-February 2013      166
  82. Leading advertisers of OTC brands in Hungary, by amount spent (HUF bn), 2012      171
  83. Top 10 brands of OTC products in terms of advertising spending in Hungary, by amount spent (HUF bn), 2010-2012      171
  84. GRP of TV campaigns of leading OTC manufacturers in Hungary, by month, January 2012-July 2013      172
  85. Number of TV broadcasts by selected leading OTC manufacturers in Hungary, by month, January 2012-July 2013      173
  86. Data on the SUKL activity in the area of drug advertising in Slovakia, 2007-2012      174
  87. Leading advertisers in the OTC industry in Bulgaria (BGN m), 2011-2012      175
  88. Leading advertisers in the OTC industry in Bulgaria (BGN m), H1 2012-H1 2013      175
  89. Top 10 leading TV advertisers in the pharmaceutical industry in Bulgaria (BGN m), H1 2011-H1 2012      176
  90. Top 12 leading TV advertisers in the pharmaceutical industry in Bulgaria (BGN m), Q1 2012-Q1 2013      176
  91. Top 5 leading radio advertisers in the pharmaceutical industry in Bulgaria (BGN), H1 2011-H1 2012      177
  92. Gedeon Richter sales in CE countries analysed (€ m), 2012-H1 2013      185
  93. Sopharma export sales, by country and region (%), 2010-H1 2013      187
  94. Top Walmark dietary supplement brands in selected CEE countries, 2012      193
  95. Sales revenue of 10 largest manufacturers on the pharmacy OTC market in Poland (PLN m), change and market share (%), 2011-2012      198
  96. Sales revenue of 10 largest manufacturers on the pharmacy dietary supplements market in Poland (PLN m), change and market share (%), 2011-2012      199
  97. Selected acquisitions of pharmaceutical companies in the OTC segment in Poland, 2012-August 2013      202
  98. Top 10 manufacturers of OTC products in Romania, by sales value (€ m), 2012      206
  99. Revenues of top 10 pharmaceutical companies in Romania on the OTC cold and flu products market, by sales value (€ m), 2012      206
  100. Top 20 manufacturers of dietary supplements in Romania, by value, Q1-Q3 2012      207
  101. Top 10 manufacturers of OTC drugs in the Czech Republic, by value (CZK m), 2012-H1 2013      212
  102. Top 10 manufacturers of OTC drugs in the Czech Republic, by volume (‘000), 2012-H1 2013      212
  103. Market share and change in sales value (%) of leading dietary supplement manufacturers in the Czech Republic, by value, October 2011-September 2012      213
  104. Top 25 manufacturers of OTC drugs in Hungary, by value, July 2012-June 2013      214
  105. Top 10 manufacturers of dietary supplements in Hungary, by value (HUF), July 2012-June 2013      215
  106. Top 10 manufacturers of OTC drugs in Slovakia, by value (€ m), at manufacturer prices, 2010-H1 2013      216
  107. Top 10 manufacturers of OTC drugs in Slovakia, by value (€ m), at consumer prices, 2012-H1 2013      216
  108. Top 10 manufacturers of OTC drugs in Slovakia, by volume (’000), 2010-H1 2013      217
  109. Sales value (BGN m), change and market share (%) of top 10 manufacturers of OTC products in Bulgaria, 2012      218
  110. Sales volume (million packets), change and market share (%) of selected leading manufacturers of OTC products in Bulgaria, 2012      218
  111. Sales value (BGN m), change and market share (%) of top 10 manufacturers of OTC drugs in Bulgaria, 2012      219
  112. Sales volume (million packets), change and market share (%) of selected leading manufacturers of OTC drugs in Bulgaria, 2012      219
  113. Sales value (BGN m), change and market share (%) of top 10 manufacturers of dietary supplements in Bulgaria, 2012      220
  114. Sales volume (million packets), change and market share (%) of selected leading manufacturers of dietary supplements in Bulgaria, 2012      220
How to buy market research report?
 

Process to buy a market research report from us

Step 1: Select publication license from Publication Type dropdown.
Step 2: Click Add To Cart button.
Step 3: The report is added to your cart and you are redirected to cart page.
Step 4: Enter Coupon Code (if applicable) and click on Apply to order button.
Step 5: Review your cart and either click on Checkout button to proceed or click on Checkout with PayPal button for Express Checkout. Please note PayPal option is not available for buyers from India.
Step 6: Enter your E-mail Address and choose your desired Username and Password for a new account or login with your existing account.
Step 7: Enter your Billing Information.
Step 8: Choose your Payment Method from either 2Checkout (default option) or PayPal and click on Review order button.
Step 9: Review your order and click on Submit order button to go to payment gateway and make payments.
Step 10: You can change your language and currency if you have selected 2Checkout as your payment option. Your billing information is pre-filled, so you can proceed to Payment Method tab.
Step 11: Enter your Credit/Debit Card details and click Submit Payment button to make payment and complete purchase process.
 
Please contact us if you need an Invoice or any other information regarding purchase process.

Do you have more questions related to this market research report after going trhough the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
13 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

SINGLE USER LICENSE (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Global License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

SITE USER LICENSE (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Global License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

GLOBAL USER LICENSE (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Note: Product cover images are only for representative purpose only and may vary from those shown above.

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Related Publications

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianB. Braun, Cobham, fiserv, Harris, Wipro, AonMunich Re, Lotte Chemical, National Post, First Data